Inflation Trends and Interest Rates: Higher inflation and potential interest rate hikes, as indicated by FOMC minutes and CPI data, can increase borrowing costs for biotech companies like Akari Therapeutics, impacting R&D and operational expenses.

Biotech Funding Environment: General economic conditions and investor risk appetite, influenced by inflation and monetary policy, directly affect the availability and cost of venture capital and public market funding crucial for early-stage biotechnology firms.

Overall Economic Sentiment: Broad market sentiment and investor confidence, shaped by global economic indicators and geopolitical events, can influence investment in higher-risk, growth-oriented biotech stocks.